Table 4. Outcome metrics of the dual-hormone VPP across the selected virtual patients.
Dual Hormone VPP | Clinical Results | Simulated Results | p-value | MAE (%) |
---|---|---|---|---|
Time in hypoglycemia (%) | 1.3 ± 1 | 0.9 ± 0.8 | 0.19 | 1.1 |
Time in hyperglycemia (%) | 26.7 ± 11.4 | 23.5 ± 5.7 | 0.21 | 8.8 |
Time in range (%) | 71.9 ± 10.9 | 75.6 ± 5.5 | 0.13 | 8.3 |
LBGI | 2.3 ± 1.3 | 1.9 ± 0.8 | 0.30 | 1.3 |
HBGI | 7.2 ± 2.3 | 6.2 ± 1.1 | 0.06 | 1.9 |